Home > Investor

Investor

Share Trends
Stock Performance
Warsaw Stock Exchange
Bulgarian Stock Exchange
Corporate News
28 October 2021
The Executive Director of Sopharma met with Vice President of Vietnam Mrs. Vo Thi Anh Xuan
Financial News
5 December 2022
Sales revenues for November 2022
29 November 2022
Conclusion of transactions from the scope of art. 114, para. 2 of the LPOS
28 November 2022
Tender offer to the shareholders of “Sopharma” AD by “Donev Investments Holding” AD
Financial Highlights 31 March, 2022
397 570
BGN '000 Revenue
34 368
BGN '000 EBITDA
21 827
BGN '000 Revenue from operating profit
22 560
BGN '000 Net profit for the year
0.17
BGN Earnings per share

Next events
10 January 2023
Financial revenues for January-December 2022
30 January 2023
Publication of Preliminary Annual Individual financial statements for 2022

Equity story

85+ year track record in the pharma industry

  • Leadership
  • Growth
  • Portfolio
  • Profitability
  • Business Model
  • M&A